Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2022-01-28 AGM Information
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Uchwały podjęte na NWZ
AGM Information Classification · 98% confidence The document text is titled 'Uchwały podjęte na Nadzwyczajnym Walnym Zgromadzeniu Mercator Medical S.A. w dniu 27 stycznia 2022 r.', which translates to 'Resolutions adopted at the Extraordinary General Meeting of Mercator Medical S.A. on January 27, 2022'. The content details multiple resolutions (Uchwała Nr 1 through Nr 7, with Nr 8 starting) passed during this meeting, including procedural matters, changes to the Supervisory Board, share cancellation, and capital reduction. This content directly relates to the formal proceedings and outcomes of a General Meeting. This aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (or Extraordinary General Meeting, as indicated by 'Nadzwyczajnym Walnym Zgromadzeniu'). It is not a proxy statement (PSI), nor is it a declaration of voting results (DVA), as it contains the resolutions themselves, not just the final tally of votes for all items.
2022-01-28 Polish
Uchwały podjęte na Nadzwyczajnym Walnym Zgromadzeniu - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document text is in Polish and translates roughly to: "The Management Board of Mercator Medical S.A. ('the Company') hereby provides, attached to this report, the content of the resolutions adopted at the Extraordinary General Meeting of the Company on January 27, 2022, along with information on objections raised to the minutes of the resolutions numbered 2, 4, and 12, and the content of the resolution that was put to a vote but not adopted." Key indicators are: 1. "Nadzwyczajnym Walnym Zgromadzeniu Spółki" (Extraordinary General Meeting). 2. "treść uchwał podjętych" (content of resolutions adopted). 3. The document is short (362 chars) and states it is providing the content of resolutions adopted at a meeting, suggesting it is reporting the results of a shareholder vote. This strongly aligns with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2022-01-28 Polish
Powołanie osoby nadzorującej - Content (PL)
Board/Management Information Classification · 98% confidence The document text is in Polish and details the appointment of Mr. Witold Kruszewski to the Supervisory Board ('Rady Nadzorczej') of Mercator Medical S.A. following a resolution passed at an Extraordinary General Meeting ('Nadzwyczajne Walne Zgromadzenie'). It provides extensive biographical and professional background information on the newly appointed member, including past roles and qualifications. This type of announcement, focusing specifically on changes in the board of directors or senior management, directly corresponds to the definition of Board/Management Information (MANG).
2022-01-28 Polish
Terminy przekazywania raportów okresowych w 2022 roku - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text, written in Polish, explicitly outlines the schedule for the company's periodic reports (quarterly, semi-annual, and annual reports) for the year 2022. It lists specific dates for the release of the consolidated annual report for 2021, Q1 2022, H1 2022, and Q3 2022 reports. It also references specific Polish financial regulations (§ 62, § 79 of the Minister of Finance Regulation). Since the document is an announcement detailing *when* reports will be published, rather than being the report itself, it fits the definition of a Report Publication Announcement (RPA). The document length (1994 chars) is short, supporting the RPA classification over a full report (like 10-K or IR).
2022-01-25 Polish
Szacunkowe wyniki czwartego kwartału 2021 r. - Content (PL)
Earnings Release Classification · 100% confidence The document text is very short (991 characters) and presents preliminary, estimated financial results (revenues, EBITDA, net loss) for the fourth quarter of 2021, comparing them to previous periods (Q4 2020, Q3 2021). Crucially, the text explicitly states: 'Skonsolidowany raport roczny Grupy Emitenta za 2021 r. jest w trakcie przygotowywania' (The consolidated annual report of the Issuer Group for 2021 is being prepared). This structure—announcing preliminary key figures for a period without being the full, audited report—is characteristic of an Earnings Release (ER). It is not the full 10-K, nor is it merely an announcement of a report's publication (RPA), as it contains the core data itself. Q4 2021
2022-01-19 Polish
Powiadomienie o transakcjach
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). This structure, referencing MAR Article 19, is the standard format for reporting personal share transactions by persons discharging managerial responsibilities (PDMRs) or persons closely associated with them. The content details the 'Nabycie' (Acquisition) of 'akcje zwykłe' (ordinary shares) by 'Orpheus Sp. z o.o.' (a person closely associated with the CEO of Mercator Medical S.A.). This directly corresponds to the definition of Director's Dealing (insider trades). Therefore, the appropriate filing type is DIRS.
2021-12-21 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.